Medication info
Selmetek Tablet 40 mg (Olmesartan Medoxomil)

Selmetek Tablet 40 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
White, rectangular, film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201504115 · Approved 2015.06.24 · Insurance code 693901570

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
1. Adults The recommended initial dose is 10 mg once daily, taken regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20 mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40 mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have reduced effective circulating blood volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. 2. Older adults No dosage adjustment is required when this medicine is administered to older adults aged 65 years or older. Although no overall differences in efficacy or safety have been observed between older and younger patients, the possibility of a more sensitive response in some older adults cannot be excluded. 3. Patients with renal impairment The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dosage adjustment is required for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, which may be increased to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
5. Children The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is a condition characterized by persistently high blood pressure; this medication helps control blood pressure, reducing the burden on the heart and blood vessels and aiding in the prevention of complications. It can lower the risk of cardiovascular diseases such as myocardial infarction and stroke. It is effective in managing blood pressure consistently in patients and contributes to overall cardiovascular health improvement. Therefore, it is used in the treatment of essential hypertension.

How to take

Adult dose

1. Adults The recommended initial dose is 10 mg once daily, taken regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20 mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40 mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have reduced effective circulating blood volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. 2. Older adults No dosage adjustment is required when this medicine is administered to older adults aged 65 years or older. Although no overall differences in efficacy or safety have been observed between older and younger patients, the possibility of a more sensitive response in some older adults cannot be excluded. 3. Patients with renal impairment The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dosage adjustment is required for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, which may be increased to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

5. Children The safety and efficacy in children have not been established.

Precautions

This medication may cause serious harm or death to the fetus and newborn if taken during the second or third trimester of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to this medication or its ingredients, pregnant or breast-feeding women, patients undergoing dialysis, those with severe liver impairment, and patients with bile duct obstruction should not take this medication. Those with lactose intolerance or certain genetic metabolic disorders should also refrain from using this medication. Patients with decreased blood volume or low salt levels may experience hypotension, so their condition should be monitored closely, and appropriate actions should be taken if hypotension occurs. Patients with severe heart failure or those sensitive to renal function may experience deterioration in kidney function; regular monitoring is necessary when taking this medication. Patients with renal disorders, kidney transplant recipients, or patients with renal artery hypertension may also show changes in kidney function, so close administration is required. Due to the risk of hyperkalemia, serum potassium levels should be checked frequently; patients with aortic stenosis or cardiomyopathy should also be cautious. Dizziness may occur while taking this medication, so it is advisable to avoid driving or operating dangerous machinery. This medication may cause side effects such as dizziness, headache, abdominal pain, and nausea, and rarely has been reported to cause angioedema, liver function abnormalities, hyperkalemia, or renal failure. If chronic diarrhea or weight loss occurs, discontinue use and consult a physician. Drug interactions may occur when taken concurrently with other antihypertensives, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so be sure to inform healthcare providers. Pregnant women should not take this medication due to serious risks to the fetus, and breast-feeding mothers should consider discontinuing use or breast-feeding due to potential adverse effects on the infant. Safety in pediatric patients has not been established, and older adults may have higher drug concentrations in the body, requiring caution. Overdosage may lead to hypotension or heart abnormalities, necessitating prompt emergency treatment.

Side effects

  • Dizziness
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
Show 27 more
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • weakness
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • hypertension
  • epistaxis
  • upper respiratory infection
  • asthma
  • cough

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 25 degrees Celsius to safely preserve the medication's effectiveness.

Appearance and packaging

Appearance

White, rectangular, film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.